Tennessee Bureau of Investigation: Trends in Law Enforcement Drug Seizures 2022

Slide Note
Embed
Share

Analyzing drug seizure trends in Tennessee, the Tennessee Bureau of Investigation report highlights the prevalence of various substances such as Tramadol, HHC, THCP, Buprenorphine, Heroin, Fluorofentanyl, and Cocaine during the first and second quarters of 2022.


Uploaded on Dec 06, 2024 | 0 Views


Download Presentation

Please find below an Image/Link to download the presentation.

The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. Download presentation by click this link. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.

E N D

Presentation Transcript


  1. Tennessee Bureau of Investigation Trends in Law Enforcement Drug Seizures

  2. Tennessee Bureau of Investigation Forensics Services/Crime Laboratory Forensic Chemistry / Drugs

  3. 2022 Q1,Q2 1 2 3 4 5 6 7 8 9 10 Tramadol 189 / 378

  4. 2022 Q1,Q2 1 2 3 4 5 6 7 8 9 delta-9-tetrahydrocannabinol Tramadol 233 / 466 189 / 378 10

  5. HHC - Hexahydrocannabinol

  6. THCP Tetrahydrocannabiphoral 30 times more potent than delta-9?

  7. 2022 Q1,Q2 1 2 3 4 5 6 7 8 9 10 Buprenorphine delta-9-tetrahydrocannabinol Tramadol 359 / 718 233 / 466 189 / 378

  8. 2022 Q1,Q2 1 2 3 4 5 6 7 8 9 10 Heroin 510 / 1,020 359 / 718 233 / 466 189 / 378 Buprenorphine delta-9-tetrahydrocannabinol Tramadol

  9. 2022 Q1,Q2 1 2 3 4 5 6 7 8 9 10 Fluorofentanyl Heroin 515 / 1,030 510 / 1,020 359 / 718 233 / 466 189 / 378 Buprenorphine delta-9-tetrahydrocannabinol Tramadol

  10. 2022 Q1,Q2 1 2 3 4 5 6 7 8 9 10 Cocaine 775 / 1,550 515 / 1,030 510 / 1,020 359 / 718 233 / 466 189 / 378 Fluorofentanyl Heroin Buprenorphine delta-9-tetrahydrocannabinol Tramadol

  11. 2022 Q1,Q2 1 2 3 4 5 6 7 8 9 4-anilino-N-phenethylpiperidine (ANPP) Cocaine 873 / 1,746 775 / 1,550 515 / 1,030 510 / 1,020 359 / 718 233 / 466 189 / 378 Fluorofentanyl Heroin Buprenorphine delta-9-tetrahydrocannabinol Tramadol 10

  12. ANPP (although schedule 2 on its own) is a precursor in the manufacturing process of fentanyl

  13. 2022 Q1,Q2 1 2 3 4 5 6 7 8 9 10 Fentanyl 4-anilino-N-phenethylpiperidine (ANPP) Cocaine 1,753 / 3,506 873 / 1,746 775 / 1,550 515 / 1,030 510 / 1,020 359 / 718 233 / 466 189 / 378 Fluorofentanyl Heroin Buprenorphine delta-9-tetrahydrocannabinol Tramadol

  14. 2022 Q1,Q2 1 2 3 4 5 6 7 8 9 10 Cannabis-Marijuana Fentanyl 4-anilino-N-phenethylpiperidine (ANPP) Cocaine 2,269 / 4,538 1,753 / 3,506 873 / 1,746 775 / 1,550 515 / 1,030 510 / 1,020 359 / 718 233 / 466 189 / 378 Fluorofentanyl Heroin Buprenorphine delta-9-tetrahydrocannabinol Tramadol

  15. Approximately 93.45% (2,269 out of 2,428) of plant material is presumptively consistent with marijuana. Approximately 6.55% (159 out of 2,428) of plant material is presumptively consistent with hemp.

  16. 2022 Q1,Q2 5,207 / 10,414 2,269 / 4,538 1,753 / 3,506 873 / 1,746 775 / 1,550 515 / 1,030 510 / 1,020 359 / 718 233 / 466 189 / 378 1 2 3 4 5 6 7 8 9 10 Methamphetamine Cannabis-Marijuana Fentanyl 4-anilino-N-phenethylpiperidine (ANPP) Cocaine Fluorofentanyl Heroin Buprenorphine delta-9-tetrahydrocannabinol Tramadol

  17. Drugs to watch Nitazenes Metonitazene Isonitazene Pronitazene N-pyrrolidino Etonitazene Flunitazene

  18. Drugs to watch Nitazenes Nitazenes are potent synthetic opioids from a drug class known as benzimidazole-opioids. Recent studies show that the potency of nitazene compounds varies, with some being 1.5-40 times more potent than fentanyl.

  19. Drugs to watch Xylazine Xylazine, a non-opioid veterinary tranquilizer not approved for human use, has been linked to an increasing number of overdose deaths nationwide in the evolving drug addiction and overdose crisis. Studies show people exposed to xylazine often knowingly or unknowingly used it in combination with other drugs, particularly illicit fentanyl.

  20. David B. Rausch Director Tennessee Bureau of Investigation Office (615) 744-4367 / Cell (629) 395-0813 David.Rausch@tn.gov

Related


More Related Content